Axa’s Madison Square Garden MSGS Stock Holding History

Axa’s Portfolio MSGS Stock Details MSGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,000	Closed	-$1.55M	–	1290
2021 Q2	$1.55M	Sell	9,000 -3,200	-26%	-$578K	﹤0.01%	927
2021 Q1	$2.19M	Buy	+12,200	New	+$2.25M	0.01%	834

Other funds holding MSGS

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

LPC

Long Pond Capital New York $1.04B AUM 2.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Axa's MSGS Position: Q3 2021 in Review

Axa sold out of Madison Square Garden (MSGS) in Q3 2021, closing a stake of 9,000 shares — an estimated $1.55M sold.

Axa first reported a position in MSGS in Q1 2021 and held it in 2 quarters. The position peaked at $2.19M in Q1 2021. 258 funds tracked by Wall St. Rank hold MSGS as of Q3 2021.

Axa reported no remaining Madison Square Garden position as of Q3 2021 after selling out during the quarter.
Axa sold 9,000 Madison Square Garden shares in Q3 2021, an estimated $1.55M.
Axa first reported a position in Madison Square Garden in Q1 2021 and held it in 2 quarters.
Axa's Madison Square Garden position peaked at $2.19M in Q1 2021.
258 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2021.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.